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osting by EAbstract Objective: To determine the frequency and signiﬁcance of thyroid auto-antibodies and
antinuclear antibody among Saudi patients with chronic urticaria and to identify markers of
chronic urticaria disease.
Materials and methods: Non-interventional, prospective analytical study carried out among con-
secutive patients with chronic urticaria in the Department of Dermatology, College of Medicine,
King Saud University, Riyadh, Saudi Arabia between January 2005 and December 2007. Patients
were divided into two groups: Group 1 – with hypothyroidism, Group 2 – without hypothyroidism,
both age-matched to normal healthy controls. All patients were investigated for the presence of
antithyroglobulin (ATG), antimicrosomal (AMA), antinuclear antibodies (ANA) as well as rheu-
matoid factor (RF) and antibodies to hepatitis B and C.
Results: A total of 90 participants were included in the study. Signiﬁcant elevation of anti thyro-
globulin antibodies was found in patients with hypothyroidism than in those without hypothyroid-
ism and in the control group (30.4% vs. 24.4% vs. nil, p= 0.022). Elevated titers of antimicrosomal
antibodies were seen in chronic urticaria patients with or without hypothyroidism compared to
control group. Positive antinuclear antibodies were detected in all groups. There were no signiﬁcantgy (82), King Khalid Univer-
.O. Box 2925, Riyadh 11461,
: +966 14672328.
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48 A.O. Al-Balbeesidifferences in the severity of the disease in between study groups (p= 0.234). Chronic urticaria was
statistically signiﬁcantly associated with hypothyroidism (p= 0.0014) and with the presence of
antithyroglobulin antibodies (p= 0.022). The duration of urticaria was signiﬁcantly associated
with positive antithyroid and anti-nuclear antibodies (p= 0.0315 and p= 0.0056, respectively).
Disease severity was not signiﬁcantly associated with elevations of ANA, TMA and TGA titers
(p= 0.558, 0.827 and 0.324, respectively).
Conclusion: Chronic immunologic urticaria may be entertained in patients with long standing urti-
caria especially in the presence of hypothyroidism and elevated antithyroid antibodies. Assays for
thyroid antibodies, TSH and ANA may be justiﬁed for early diagnosis of autoimmune urticaria to
institute appropriate treatment modalities, hence improve the quality of life.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Urticaria is a common dermatosis observed in 15–25% of the
general population and 25% of urticaria is chronic (Leznoff,
1998; Sharma and Miller, 1993). Chronic urticaria is character-
ized by recurrent, itchy, transient macula-papular rash with or
without angioedema lasting for more than 6 weeks (Greaves,
1995; Turktas et al., 1997). Patients with chronic urticaria have
impairment in the quality of life similar to patients with psori-
asis, acne and heart disease (O’Donell et al., 1997; Poon et al.,
1999; Yosipovitch and Greaves, 2008). The probable lethal
risk of laryngeal edema and the inﬂuence of urticaria on qual-
ity of life make this skin condition a true health concern
(O’Donell et al., 1997).
Despite extensive investigations no cause is identiﬁed in the
majority of patients, thus remains idiopathic (Greaves, 2000;
Tong et al., 1997). The prevalence of thyroid function altera-
tions in such patients as well as the efﬁcacy of correcting these
alterations has been discussed in many studies but it remains
questionable (Zauli et al., 2002).
Furthermore, around 10–40% of patients with chronic urti-
caria were found to have antibodies to FC epsilon R1 (IgE
receptors), IgE or both in the sera of patients (Tong et al.,
1997; Zauli et al., 2002; Collet et al., 1995; Grattan et al.,
1992; Kaplan and Greaves, 2009). It has been reported in pre-
vious studies that the frequencies of antithyroid antibodies,
such as antithyroglobulin (TGA), antimicrosomal (TMA) or
antithyroperoxidase antibodies (TPO) were found to be signif-
icantly higher in patients with chronic urticaria (Zauli et al.,
2001). In addition, an association has been reported between
hepatitis C and chronic urticaria (Broussolle et al., 1999;
Fernandez-Soto et al., 1998).
2. Methods
This non-interventional, prospective analytical study was car-
ried out in the Department of Dermatology, College of Medi-
cine, King Saud University, Riyadh, Saudi Arabia between
January 2005 and December 2007 among patients with chronic
urticaria of more than six weeks in duration.
Patients were divided into two groups; Group 1 consisted of
chronic urticaria patients with hypothyroidism and Group 2
consisted of chronic urticaria patients without hypothyroid-
ism. For comparison, a separate group of patients were re-
cruited which comprised normal healthy age-matched
controls. In all patients ANA, TGA and TMA were measured.
A hemagglutination technique titer of <1:10 was considered
negative for TGA and <1:100 was negative for TMA. ANAwas positive if titer reads 1:80 or above. TSH and T4 were
measured by radioimmunoassay. Hypothyroidism was diag-
nosed clinically together with a TSH level >5 mIU/L. All pa-
tients including the controls were investigated for the presence
of antithyroglobulin, antimicrosomal, antinuclear antibodies
as well as antibodies to hepatitis B and C to exclude known
causes of urticaria.
Data were collected and analyzed using Predictive Analysis
Software version 18 (PASW, SPSS Inc., IBM-SPSS, Chicago,
Illinois, USA). Demographic frequencies were expressed as
mean ± standard deviation (SD) or as percentage distribution.
The group statistics were assessed using students’ t-test for
paired samples or Fisher’s exact test as appropriate. The
relationship between urticaria duration, family history and
auto-antibodies was evaluated using Fisher’s exact test or
Chi-square test, when appropriate. Two-tailed p value of
<0.05 was considered statistically signiﬁcant.
3. Results
There were 23 patients with chronic urticaria with hypothy-
roidism (Group 1) and 45 patients with chronic urticaria with-
out clinical or biochemical hypothyroidism (Group 2).
Twenty-two participants comprised the normal healthy age-
matched controls. Patients with chronic urticaria without
hypothyroidism were signiﬁcantly younger compared to those
with hypothyroidism (37.9 ± 15.6 years vs. 46.2 ± 12.6 years,
p= 0.03). There is signiﬁcant preponderance to the female
gender in both study groups (100% and 84.4%, p= 0.047).
The mean duration of urticaria was relatively longer in pa-
tients with hypothyroidism than in those without hypothyroid-
ism (6.3 ± 6.0 years, range: 6 months to 25 years vs. 4.4 ±
4.4 years, range: 2 months to 25 years, p= 0.138).
Table 1 describes the comparison of frequencies of TGA,
TMA and ANA between the study groups and the control
group. There were 30.4% of patients in Group 1 who had ele-
vations of TGA, 24.4% of Group 2 and none among the
healthy controls (x2 = 0.022). There were no signiﬁcant differ-
ences in the mean TGA titers observed in between study
groups (p> 0.05), however, signiﬁcant elevations of TGA ti-
ters were observed among the study patients compared to
the healthy group (18/68 or 26.5% vs. none, p< 0.0001).
There were 26.1% of patients in Group 1 who had elevations
of TMA, 26.7% of Group 2 and 4.5% among the healthy con-
trols (x2 = 0.09). There were no signiﬁcant differences in the
mean TMA titers observed in between study groups
(p> 0.05), however, signiﬁcant elevations of TMA titers were
observed among the study patients compared to the healthy
Table 1 Comparison of frequencies of antithyroglobulin, antimicrosomal and antinuclear auto-antibodies among chronic urticaria
patients with and without hypothyroidism.





TGA 7 11 18 0
(>1:10 positive) (30.4%) (24.4%) (26.5%) (0%)
TMA 6 12 18 1
(>1:100 positive) (26.1%) (26.7%) (26.5%) (4.5%)
ANA 1 11 12 4
(4.3%) (24.4%) (17.6%) (18.2%)
Signiﬁcance of antithyroid antibodies 49group (18/68 or 26.5% vs. 4.5%, p< 0.0001). There were
4.3% of patients in Group 1 who had elevations of ANA,
24.4% of Group 2 and 18.2% among the healthy controls
(x2 = 0.004). A signiﬁcantly higher percentage of patients
without hypothyroidism had elevations of ANA compared to
those with hypothyroidism (p= 0.037), however, there were
also a signiﬁcant percentage of normal healthy controls who
had elevations of ANA (18.2%, p= 0.047). There were no sig-
niﬁcant differences in the percentage of patients who had ele-
vations of ANA between the study group and the control
group (p= 0.823).
Thirty-eight patients had the disease for more than 3 years.
Of these, 4 (of 23 patients in Group 1 or 25%) and 13 (of 45
patients of Group 2 or 59.1%) were positive for antithyroid
antibodies, (p= 0.0315), (Table 2).
According to disease severity, of 23 patients with chronic
urticaria and hypothyroidism, 10 (43.5%) had moderate dis-
ease severity and 3 (13.0%) had severe disease. On the other
hand, among patients with chronic urticaria without hypothy-
roidism, 24 (51.1%) had moderate disease severity and 7
(14.9%) had severe disease. There were no signiﬁcant differ-
ences in the severity of the disease in between study groups
(p= 0.234) Furthermore, there were no signiﬁcant correla-
tions between disease severity and ANA (p= 0.558), TGA
(p= 0.827) and TMA (p= 0.324) titers.
Of the 23 patients with hypothyroidism, 6 (26.1%) had po-
sitive family history of hypothyroidism. Sixteen (69.6%) of
these patients had urticaria more than 3 years duration. On
the other hand, of 45 patients without hypothyroidism, 7
(15.6%) had a positive family history of hypothyroidism.
Twenty-two (48.9%) of these patients had urticaria for more
than 3 years Family history of hypothyroidism was not corre-
lated to the duration of urticaria.
Rheumatoid factor was negative in all patients, and none of
the patients tested positive for ANA had evidence of connec-Table 2 Comparison of frequencies of antithyroid and
antinuclear antibodies in chronic urticaria patients with or












Antithyroid antibodies 4 (25%) 13 (59.1%)
Antinuclear antibody 0 (0%) 10 (45.5%)tive tissue disease. Two patients (one from Group 1 and an-
other one from Group 2) tested positive for hepatitis B.
4. Discussion
Our study showed that most of our patients had chronic urti-
caria (duration > 3 years) with greater preponderance to the
female gender which is in concordance with the report of
Leznoff and Sussman (1989) whichfemale to male percentages
in Groups 1 and 2 were (100:0%) and (84:15.6%), respectively,
indicating more female predominance in patients of chronic
urticaria with hypothyroidism, which is consistent with the
published data (Leznoff and Sussman, 1989). The ﬁndings of
a signiﬁcantly younger age population of chronic urticaria pa-
tients without hypothyroidism are understandable since thy-
roid autoimmunity and hypothyroidism may appear several
years after the onset of urticaria (Levy et al., 2003).
The elevated titers of antithyroglobulin antibodies and
AMA in patients with chronic urticaria and hypothyroidism
in both study groups when compared to controls were consis-
tent with the ﬁndings of Turktas et al. (1997) (O’Donell et al.,
1997; Broussolle et al., 1999) where elevations of TGA and
TMA were as much as 11.7% and 9.6% of patients (O’Donell
et al., 1997; Broussolle et al., 1999). In another study, elevated
titers of TGA were also found in as much as 30% of patients
with chronic urticaria and as much as 80% in patients with
hypothyroidism with or without urticaria (O’Donell et al.,
1997; Aamir et al., 2008).
Our study conﬁrms the relationship between chronic urti-
caria and thyroid autoimmunity as suggested in previous stud-
ies (O’Donell et al., 1997; Aamir et al., 2008). These elevations
in TGA and TMA represent an abnormal thyroid function in
chronic urticaria patients, however, the pathogenesis in the
context of chronic urticaria associated to thyroid auto-
antibodies remains vague. The signiﬁcance of the association
lies in the different autoimmune mechanisms found in both
disorders (O’Donell et al., 1997; Greaves, 2000).
Elevated AMA antibodies were likewise found in 43.3%
with chronic urticaria and as much as 90% in patients with
hypothyroidism, with or without urticaria (Toubi et al.,
2004). In this study positive antinuclear antibodies
(ANA> 1:80) were detected in one patient (4.35%) in
Group 1; 11 patients (24.4%) in Group 2 and four patients
(18.18%) in the control group which may indicate higher
incidence of ANA positivity among chronic urticaria pa-
tients without hypothyroidism, thus more apt to be a mar-
ker of autoimmunity (Gurber et al., 1988; Sabroe et al.,
1999; Godse, 2004).
50 A.O. Al-BalbeesiIn our study, we found no signiﬁcant differences in the sever-
ity of the disease in between study groups. This suggests that
whether chronic urticaria patients present with or without hypo-
thyroidism, the severity of the condition is unaffected. These
ﬁndings conform to the previous study which stated that pa-
tients may still suffer from chronic urticaria after 3 years or even
more, despite the absence of hypothyroidism. Although we
found no signiﬁcant associations between duration of urticaria
with family history of hypothyroidism or the disease severity,
there might be other confounding factors that in one way or
the other correlate the existence of such unique factor in a partic-
ular patient and makes it peculiar sometimes. Furthermore, in
this study, among patients of chronic urticaria of more than
3 years duration, the frequency of antithyroid antibodies posi-
tivity increases signiﬁcantly. Our ﬁndings suggest a strong asso-
ciation between the duration of urticaria with the signiﬁcant
elevations of antithyroid antibody titers and also positivity to
ANA.Thus, early identiﬁcation of patientswhose urticaria is ex-
pected to be chronic warrants an immunological work-up. If
TGA and TMA are present in high titers, this may support the
diagnosis of chronic immunologic urticaria. The plasma levels
of thyrotropinmayhelp in the screening for thyroid dysfunction.
Urticaria is one of the extra hepatic manifestations of hep-
atitis B and C (Reichel and Mauro, 1990). It might occur as
part of the prodromal phase of hepatitis B infection along with
fever and arthralgia. In a study conducted by Chen et al.
(2009) (19.3%) of their 150 patients of chronic urticaria were
found to have higher incidence of positive HbsAb as compared
to controls (10%) (Broussolle et al., 1999; Fernandez-Soto
et al., 1998; Chen et al., 2009).
Chronic urticaria associated with HCV infection could
make a distinct clinical entity characterized by older age group
(53 years), longer lasting eruption, detectable HCV RNA and
abnormal liver function test with an indication for interferon
therapy (Broussolle et al., 1999; Fernandez-Soto et al., 1998;
Kazuya et al., 1996). Moreover, both hypothyroidism and thy-
roid auto-antibodies are more common in patients with chronic
hepatitis C even in the absence of cirrhosis, hepatocellular car-
cinoma, or interferon therapy than in those with chronic hepa-
titis B infection and in controls (Broussolle et al., 1999;
Fernandez-Soto et al., 1998; Alessandro et al., 2004).
In recent reports thyroid dysfunction and elevated Thyro-
peroxidase antibodies were the most frequently reported unto-
ward side effects among patients receiving interferon therapy
for hepatitis C reaching as high as (6%) (Dusheik, 1997).
Screening patients for hepatitis B and C might be of signif-
icance to exclude other underlying causes of thyroid disease,
auto-antibodies and urticaria.
Because of the associations between thyroid dysfunction
and chronic urticaria, thyroid function screening, detection
of auto-antibodies, and ANA titers may be advisable to deter-
mine an underlying autoimmune disorder. This may serve as
an adjunct in the diagnosis of patients with chronic urticaria
for early identiﬁcation and detection of the underlying thyroid
dysfunction and autoimmunity.Acknowledgements
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